Suitable for studies involving GHRH-receptor pathway characterization and method development in model systems.Not for human use
Cagrilintide applies an analogous half-life-extension logic to a different peptide family, which is part of why the two molecules were later studied together
Most practitioners recommend starting at 250-300 mcg daily to assess tolerance, then potentially increasing to 400-500 mcg if initial response is suboptimal and no side effects occur
A.HaddadD.CraessaertsK.De BockP
Therefore, the two peptides may be used to provide a rapid onset of action with Ipamorelin and prolonged effects with CJC-1295
Remarkably, injectable GHK-Cu in one body area (thigh muscles) improved healing at distant locations (ears), demonstrating systemic enhancement that strongly increased collagen production, angiogenesis, and wound closure throughout the body